Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and Immunologic Reset in New Onset T1DM
NCT03182426Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Aug 2017
- Primary completion
- Jul 2024
- Modality
- Monoclonal Antibodies, Cytokines & Interferons, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor, alemtuzumab, anakinra, etanercept, liraglutide in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Started Aug 2017; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03182426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182426.